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Abstract
Introduction 
Information on external validity enables public health practitioners to generalize conclusions about an intervention to 
future or different conditions and is critical to moving research into practice. Prior reviews examining external validity 
focused on efficacy publications only. Our objective was to determine the extent to which secondary articles could 
enhance information about external validity presented in efficacy studies.
Methods 
We identified a group of interventions recommended by the Guide to Community Preventive Services for home-based 
depression care management for older adults. We searched online databases for secondary articles using a list of the 
study authors’ names and study acronyms. Five articles were ineligible (intervention was not effective or articles lacked 
data on external validity) and 14 articles were eligible and reviewed (6 efficacy and 8 secondary articles). We examined 
15 elements of external validity based on 4 of the 5 dimensions of the RE-AIM framework: reach, adoption, 
implementation, and maintenance.
Results 
The 6 efficacy studies documented 1 or more elements of reach and implementation, and 5 studies included 1 or more 
elements of maintenance. Secondary articles included 4 to 9 elements on external validity and addressed 1 to 5 unique 
elements of external validity not reported in the efficacy publications.
Conclusion 
Secondary articles enrich the amount of information about external validity and may be published years before or after 
the efficacy publication. Reviewing only primary publications of efficacy trials may provide a limited view of external 
validity, at least for publications describing home-based depression care management.
Introduction
In 2007, Frederick and colleagues reviewed the evidence for community-based depression interventions for older 
adults and concluded that sufficient evidence exists to support the effectiveness of depression care management 
(DCM) strategies (1). Subsequently, the Task Force on Community Preventive Services (2) recommended DCM 
interventions for the management of depressive disorders among older adults. DCM involves a trained practitioner (or 
care manager) who works in consultation with primary care providers, psychiatrists, and other members of a 
multidisciplinary team to provide depression care. This collaborative approach to depression management is based on 
the chronic care model, which encourages linkages between community and health care systems to provide care that is 
population-based, evidence-based, and patient-centered (3–5).
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To improve the health of the population, we need to focus on translating effective interventions into public health 
practice. Information on external validity enables public health practitioners to generalize conclusions about a 
program to future or different conditions and is critical to facilitating research translation (6). Prior reviews (7,8) have 
documented a dearth of information on external validity in articles describing the primary efficacy results (herein 
referred to as efficacy articles) of health promotion interventions. No study has examined whether an array of 
secondary articles contain information about external validity. Thus, our objective was to determine the extent to 
which secondary articles about DCM interventions enhance information about external validity when combined with 
information from the efficacy articles identified in the review conducted by Frederick and colleagues. This information 
can aid practitioners and decision makers in identifying factors important for adoption and implementation of these 
interventions and making more confident decisions about potentially translating these interventions into practice. We 
focus on home-based DCM interventions (herein referred to as DCM home interventions) because the evidence shows 
that these interventions are “applicable to communities in the United States and elsewhere, including diverse home 
settings (public housing, residential facilities, home care clients)” (2).
Methods
Frederick and colleagues described their search strategies, search terms, and approaches for identifying eligible 
interventions for depression management (1). In brief, their systematic review considered all study designs, including 
interventions that targeted depression as a main or secondary outcome. Eligible studies defined depression on the 
basis of either clinical criteria (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) or a score from 
an assessment instrument. The authors searched multiple online databases (eg, MEDLINE, PsycInfo, CINAHL) using 
12 Medical Subject Headings (eg, aged, depressive disorder, preventive health services) and 21 text words (eg, geriatric, 
collaborative care, primary care, home). A 14-member expert panel assessed the quality of the studies in different 
categories of interventions and the magnitude of response or robustness of individual interventions in each category 
(1). Using an approach similar to that used by the Guide to Community Preventive Services, the panel members 
determined that the DCM home intervention category had adequate data to provide an overall rating, and they rated 
this category as effective. The DCM home intervention category had 8 efficacy studies.
We excluded 2 efficacy studies (Appendix) from our review (Figure) because the interventions studied had no 
significant effect on improving depression and were not the focus of subsequent publications demonstrating their 
efficacy. We compiled a list of all of the authors and study acronyms (eg, PATCH, PEARLS) of the remaining 6 DCM 
home interventions and used this list to conduct targeted searches of PubMed and Google Scholar. The goal of these 
searches was to identify all articles, regardless of publication date (ie, even if they predated the efficacy article), that 
were related to the DCM home interventions and published before June 1, 2012. We identified 11 secondary articles 
related to 5 DCM home interventions. Three secondary articles did not contain information on external validity and 
were excluded (Appendix): 2 compared different case finding methods and 1 was a secondary analysis describing 
patterns of antidepressant use. Thus, 6 efficacy (9–14) and 8 secondary articles (15–22) were eligible for this review. In 
addition to reviewing efficacy and secondary articles, we also reviewed study websites to determine whether they 
included information on external validity. We identified these websites by conducting Google searches using study 
acronyms (eg, PATCH, PEARLS).
Figure. Flow diagram of process used to identify eligible efficacy and secondary articles of depression care 
management (DCM) home interventions for older adults. The initial 8 articles were identified in the systematic review 
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of depression interventions conducted by Frederick and colleagues (1). [A text description of this figure is also 
available.]
The RE-AIM framework (23) is a program evaluation 
and planning tool that emphasizes 5 aspects of external 
validity for facilitating research translation: reach (eg, 
representativeness of the sample); effectiveness (eg, the 
intervention’s effect on the primary outcome); adoption 
(eg, setting and resources necessary to implement 
intervention); implementation (eg, description of the 
intervention); and maintenance (eg, program 
sustainability). Our abstraction tool (Box) was based on 
this framework and consisted of a checklist (present or 
absent) of 15 elements of external validity. Because the 
effectiveness of the 6 DCM home interventions was 
already documented in Frederick and colleagues’ 
review and by the Guide to Community Preventive 
Services (2), we collected information on the remaining 
4 dimensions of the RE-AIM framework: reach (5 
elements); adoption (3 elements); implementation (4 
elements); and maintenance (3 elements). We 
abstracted information on external validity from the 
efficacy and secondary articles and resolved any 
discrepancies in abstraction through discussion.
Results
The 6 eligible efficacy studies of DCM home 
interventions were published between 1994 and 2004. 
They were conducted in the United Kingdom (9,14), 
Australia (12), Canada (10), and the United States 
(11,13). Five studies were randomized trials, with 1 (10) 
a pre-post trial. Three studies (9,12,14) enrolled older 
adults with depression, whereas the other 3 enrolled 
older adults with minor depression or dysthymia (11), 
various psychiatric disorders (including depression) 
(13), and substance abuse with depression (10).
One efficacy study (11) reported information on 9 of 15 
elements of external validity, with the remainder 
reporting 6 to 8 elements (Table). The 6 studies 
included information on at least 1 element of reach and 
implementation, and 5 of the 6 studies included 
information on at least 1 element of maintenance. All 6 
studies included information on 3 elements of reach 
(target population, eligibility criteria, and participation 
rate) and described the intervention components. Four 
studies described the specific level of training (eg, 
psychiatric nurse) of the care manager (10,11,13,14) and 
included information on the number and duration of 
intervention sessions delivered to participants (ie, 
intervention intensity) (9,11,13,14). Two studies (9,12) 
described whether the overall intervention or treatment 
plans were implemented as planned (ie, intervention 
fidelity) and only 1 study (11) reported the intervention 
costs per subject. Five of the 6 described the long-term 
effects (6 months or greater) of the intervention on depression outcomes (9–13). No study presented information on 
comparisons of the participants with nonparticipants or the target population, funding requirements for intervention 
personnel, whether the program was sustained after the end of the study, or any necessary modifications or 
adaptations that were made to the intervention for another condition.
One study (10) had no related secondary articles, 1 (9) had no eligible secondary articles (Appendix), 2 (12,13) had 1 
eligible secondary article apiece, and 2 (11,14) had multiple eligible secondary articles. The 8 eligible secondary articles 
Box. Checklist of Elements Used to 
Abstract Information on External 
Validity From Efficacy Studies and 
Associated Secondary Articles of 
Home-Based Depression Care 
Management Interventions for 
Older Adults
Reach
• Described a method for identifying the target 
population
• Described eligibility criteria
• Included participation rate
• Compared participants with nonparticipants
• Compared participants with the broader 
population
  
Adoption
• Specified necessary skills or expertise for case 
manager
• Described training procedures for personnel 
delivering intervention
• Described costs to support intervention 
personnel
  
Implementation
• Described intervention components 
• Described intervention intensity (number and 
duration of sessions delivered to participants)
• Assessed fidelity to intervention (whether the 
overall intervention or treatment plans were 
implemented as planned)
• Described measures of cost per person
  
Maintenance
• Assessed long-term effects (at least 6 months 
postintervention)
• Described whether intervention program was 
sustained after the study ended
• Described whether intervention was modified or 
adapted to another condition
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were published between 1992 and 2011 and were related to 4 efficacy studies. Waterreus presented details about the 
study methods in a secondary article (15) that predated publication of the efficacy article. Another study (11) had 2 
secondary articles published 6 and 7 years after publication of the efficacy findings.
Overall, secondary articles included information on 4 to 9 elements of external validity. For 2 (13,14) of the 4 efficacy 
studies, secondary articles addressed 1 or more elements of reach, adoption, implementation, and maintenance. Three 
secondary articles (15,18,19) described aspects of adoption, such as required skills or expertise of the care managers 
and procedures for training personnel. A secondary paper (19) was the only paper among all of the articles reviewed 
(efficacy and secondary) to describe the funding required to support intervention personnel. Secondary articles to 
studies by Rabins and Waterreus provided more details about intervention intensity (15–18) and fidelity to the 
intervention treatment plan (15–17). Finally, secondary articles to the 4 efficacy studies that had related secondary 
articles provided information either on long-term effects of the intervention on depression (17,18), program 
sustainability (18,19), or modifications (18,19). Authors of 1 efficacy study (11) posted information on program 
sustainability on a study website (www.pearlsprogram.org) and published 2 articles (21,22) on the effects of adaptation 
of the intervention to people with a specific chronic disease (epilepsy).
Secondary publications addressed 1 to 5 unique elements of external validity not presented in the efficacy publications. 
Considering the external validity data presented in the efficacy and secondary articles together, Ciechanowski (11) and 
Llewellyn-Jones (12) addressed the most elements (11 each). Overall, Rabins (13) addressed 9 elements of external 
validity and Waterreus (14) addressed 8 elements. Efficacy articles by Banerjee (9) and Brymer (10), which did not 
have secondary publications, addressed 7 and 6 external validity elements, respectively.
Most studies presented information on reach and implementation. Reach was described either in the efficacy or 
secondary articles, focusing mainly on descriptions of the target population, eligibility criteria, and participation rate. 
No study provided information necessary to assess whether the participants were representative of the target 
population or how comparable they were to nonparticipants. In terms of adoption, only 1 efficacy study (12) provided 
information on funding requirements for intervention personnel in a secondary paper (19). Regarding implementation, 
all of the efficacy articles described the intervention, but 2 did not provide information on intervention intensity. Only 
1 efficacy study (11) provided information on intervention costs, and only 2 efficacy articles (9,12) and 3 secondary 
articles (15–17) described the fidelity of intervention delivery to the original intervention or treatment plans. Five 
efficacy studies (9–13) reported on maintenance, and for 1 efficacy study (14), this information was only reported in 
the secondary article (17). Two efficacy studies (11,12) presented information on program modifications or adaptations 
in secondary articles (19,21,22). Four studies (11–14) provided information on lessons learned in the efficacy or 
secondary articles (14,18,19) or on a website (www.pearlsprogram.org).
Discussion
During the past several years, policy makers and investigators have noted the need for more rapid translation of 
advances in prevention and treatment into clinical and public health practice (24–26). At the same time, there is 
growing recognition by the public health community that promising interventions, which are often developed under 
ideal circumstances, may be difficult to replicate in everyday practice (24,27). This failure of the “research to practice” 
transition may be due to a lack of critical information on the contextual factors of external validity that decision 
makers need to determine whether a particular intervention is applicable to their specific settings, populations, and 
available resources (5,24). Our findings indicate that secondary articles contain valuable information on external 
validity.
Like prior reviews of various public health interventions (7,8), our review of the external validity of DCM home 
interventions found that all contained information on aspects of reach, such as target population, eligibility criteria, 
and participation rate. The high degree of reporting on reach is understandable, as these details provide information 
on the representativeness of the subjects receiving the intervention and is the 1 aspect of external validity emphasized 
in reporting guidelines such as the CONSORT criteria. We also found that the efficacy articles contained little 
information related to elements of adoption, implementation, and maintenance. However, we encourage caution in 
directly comparing our findings to other reviews due to differences in how researchers may have operationalized 
external validity for the purpose of abstracting information from studies.
Our review extends the methods used in other reviews of external validity because we also reviewed all secondary 
articles related to the efficacy studies describing DCM home interventions. Because of this novel approach, we found 
that secondary articles enhanced the information on external validity (eg, implementation) that was presented in the 
efficacy articles. However, we also found that the secondary articles addressed 1 to 5 unique elements of external 
validity that were not addressed in the efficacy publications. In particular, secondary articles were instrumental in 
describing factors related to maintenance, such as program sustainability and modification and adaptation of the 
interventions to other conditions. None of this valuable information was available in the efficacy articles. Thus, by 
reviewing secondary articles, some of which were published before or years after the efficacy article, we gained a more 
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complete understanding of the external validity of DCM home interventions, which may facilitate the uptake of these 
interventions by the public health community.
The lack of information about external validity in efficacy articles may relate to reporting guidelines that have been 
widely adopted by journals and place emphasis on reporting elements related to the internal validity of interventions 
(24,28). In 2006, 12 editors of public health and health promotion journals recommended that authors provide more 
information on external validity (6). In particular, they called for more frequent reporting of the following aspects of 
external validity:
Recruitment and selection procedures, participation rates, and representativeness of participants, intervention 
staff, and delivery settings.
•
Level and consistency of implementation among program components, settings, staff, and time.•
Intervention’s effect on various outcomes, especially outcomes important to populations, practitioners, and 
decision makers (eg, quality of life, program costs, adverse consequences).
•
For follow-up reports, information on the rate of attrition at all levels (ie, study participants, intervention staff, 
and delivery settings), long-term effects on outcomes, and program institutionalization, modification, or 
termination.
•
We agree with these recommendations and suggest that secondary articles may represent another venue in which 
investigators can provide more details regarding external validity. We propose that practitioners interested in a 
particular intervention perform a thorough search of the literature to identify associated articles that may contain this 
information. Moreover, summaries of external validity information that are posted on a program website and that 
contain links to publications would help to ensure greater accessibility by the practice community.
Several strengths and limitations should be considered when reviewing our findings and their implications. A strength 
of this review is our use of elements from a well-established framework to abstract information on external validity 
from the articles. Second, by limiting the focus of our review to efficacy studies of effective DCM home interventions, 
our approach more likely reflects the real-world approach of decision makers, because they are less likely to consider 
implementing interventions that are not effective. Our review of secondary articles shows that they can contribute 
toward a more comprehensive understanding of the external validity of an intervention.
Conversely, our findings are based on information abstracted from publications only; we made no attempt to contact 
study investigators. Thus, we do not know why some external validity elements were reported and others were not. 
However, our approach is likely to replicate the typical approach of practitioners when they examine an intervention, 
and our findings reinforce the need to expand beyond a review of efficacy publications. Second, our review focused on 
the external validity of DCM home interventions identified in a 2007 systematic review of depression interventions (1), 
and efficacy articles describing new DCM home interventions may have been published since then. Our primary 
objective was to complement our understanding of the internal validity of effective DCM home interventions identified 
by Frederick and colleagues and recommended by the Guide to Community Preventive Services by examining the 
external validity of these interventions. Thus, identifying and characterizing the internal validity of new DCM home 
interventions was beyond the scope of our study. However, in our searches for secondary articles, we did update the 
findings related to the interventions identified in the 2007 review, including the adaptation of the PEARLS program to 
adults with a specific chronic condition, epilepsy (21,22).
Our findings indicate that external validity data may be present in articles other than efficacy publications. 
Practitioners who are interested in a particular intervention should consider reviewing secondary articles, because 
these articles may contain additional information about external validity that can aid in research translation. These 
articles may be published years before or after the efficacy publication. Investigators could facilitate a more rapid 
translation of research into practice by summarizing and posting key aspects of external validity on accessible websites 
and providing links to relevant publications as they become available.
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Table 
 
Table. Elements of External Validity  Presented in Efficacy and Secondary 
Articles of Home-Based Depression Care Management Interventions  for 
Older Adults
Elements
Banerjee 
(Efficacy) 
(9)
Brymer 
(Efficacy) 
(10) 
Ciechanowski (11)
Llewellyn-Jones 
(12) Rabins (13) Waterreus (14)
Efficacy Secondary Efficacy Secondary Efficacy Secondary Efficacy
Reach
Method to 
identify target 
population
X X X X X (18) X
Eligibility 
criteria
X X X X X X
Participation 
rate
X X X X X X
Participants to 
nonparticipants 
comparisons
Participants to 
target 
population 
comparisons
Adoption
Level of 
expertise (eg, 
training) of 
care manager
X X (19) X (18) X
a
b
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Elements
Banerjee 
(Efficacy) 
(9)
Brymer 
(Efficacy) 
(10) 
Ciechanowski (11)
Llewellyn-Jones 
(12) Rabins (13) Waterreus (14)
Efficacy Secondary Efficacy Secondary Efficacy Secondary Efficacy
Training 
procedures for 
intervention 
personnel
X (19) X (18)
Funding of 
personnel
(19)
Implementation
Intervention 
components
X X X (20) X (19) X (18) X
Intervention 
intensity 
(number and 
duration of 
sessions 
delivered to 
participants)
X X X (18) X
Fidelity to 
intervention 
(whether the 
overall 
intervention or 
treatment 
plans were 
implemented 
as planned)
X X
Intervention 
costs per 
person
X
Maintenance
Long-term 
assessment 
(time)
X (6
months)
X (6
months)
X (12
months)
X (9.5 
months)
X (26 
months)
(18) (9 
years)
Program 
sustained after 
end of study
Web (19) (18)
Intervention 
modified or 
adapted to 
another 
condition
(21,22) (19)
 The external validity elements were based on the RE-AIM framework (23). Elements reported in the efficacy article are 
denoted by an “X,” and elements present in the secondary articles are denoted by the reference number. 
 Home-based depression care management interventions were identified in the systematic review of depression 
interventions conducted by Frederick and colleagues (1). 
 The authors posted information on program sustainability on a study website (www.pearlsprogram.org).
Appendix. List of Efficacy and Secondary Articles That 
Were Excluded From This Review
Efficacy articles of depression care management interventions (home)
Reason for exclusion: interventions were not effective in improving depression outcomes. These 2 interventions were 
included in the systematic review of depression interventions conducted by Frederick and colleagues (Frederick JT, 
c
a
b
c
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